Date: January 25th, 2024
Time: 11 AM – 12:30 PM (CET)
Title: CHAI Webinar – Go-to-market (GTM) toolbox launch: Leveraging global health resources to support GTM strategy development
Description: Through collaborative efforts with partners, CHAI has created a comprehensive toolbox, featuring a range of resources tailored to assist manufacturers in answering common questions encountered during the vaccine development journey, specifically concerning their GTM strategies. Within this toolbox, diverse resources are available, from directing manufacturers to pertinent data sources that offer insights for refining GTM strategies, providing transparency in tender processes and incorporating valuable details on decision-making processes at the country level. Notably, CHAI has developed new resources within the toolbox to address information gaps, while concurrently streamlining access to crucial existing resources generated by global partners, including Gavi, UNICEF, WHO, Linksbridge, and PATH.
During this DCVMN webinar, CHAI will provide an overview of this new toolbox, which is now hosted on the DCVMN website. The webinar will also take the audience through several of the resources included in the toolbox that can support DCVM’s as they develop their GTM strategies for LMICs.
Name: Ms. Navpreet Singh
Position: Program Manager – Vaccine Markets, CHAI
Biography: As a Program Manager within the Vaccine Markets team at CHAI, she focuses on enhancing access and affordability of Gavi-supported antigens for countries by collaborating with DCVMs in bringing their products to market for LMICs. She has over 6 years of experience in the vaccines domain, including at MSD where she led vaccine policy and advocacy work across their HPV and pneumococcal vaccine portfolios. Her academic background includes a Master of Public Health from the London School of Hygiene and Tropical Medicine.
Name: Mr. Rakesh Anand
Position: Associate – Vaccine Markets, CHAI
Biography: As an Associate on the Vaccine Markets team at CHAI, Rakesh specializes in enhancing the market health of antigens with outbreak potential, including measles, malaria, typhoid, and cholera. His prior experience at Abbott and Novartis involved providing instrumental support for the successful commercial launches of various healthcare products, leveraging his expertise in business analytics.